News
Stay up-to-date. In our news section we regularly inform you about the latest news from HWI group.
Merry Christmas
The second year in a row was challenging for all of us in many ways. As the year comes to an end, we are pleased to be able to look back on a good and satisfactory year.
We are proud to present our new SEM-EDX system
SEM-EDX combines high-resolution imaging with elemental identification in a spatial manner.
HWI blog: The way of process digitalisation in pharmacovigilance
HWI group is being completely digitalised ICSR processing in pharmacovigilance. What are the main advantages of a digital process flow and how does low-code / no-code help to digitalise complex processes in an interdisciplinary setting? Get all the answers in our HWI-blog by Dr Lisa Held and Thomas Wessling
Read more … HWI blog: The way of process digitalisation in pharmacovigilance
Coronavirus measures of the HWI group
Until further notice, the HWI group will take the following measures to ensure that our services are maintained for you.
Click on "Read more" and read the measures in detail.
Video -> Drug Development
Have a look: In our video you get an overview of our services in drug development
HWI blog: Troubleshooting
Unexpected quality problems in pharmaceutical manufacturing require a reliable root cause analysis as well as quality and safety assessment followed by the definition of preventive measures to avoid such incidents.
Find out what this means in detail in our HWI-blog by Dr Sandra Huertgen.
30 years HWI
30 years ago: On January 8th, 1991, the company was founded by Dr. Stefan Wissel and Prof. Dr. Hanns Häberlein. The two university friends created the name HWI from the first letters of their last names.
Expansion of the Management Team
As of January 1st, 2021, Dr Frank Böttcher will be appointed to the management team of HWI pharma services GmbH and will strengthen the current management team of Dr Stefan Wissel and Dr Melanie Kerst.
You will find further information in our press release.